148 related articles for article (PubMed ID: 33727019)
1. Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues.
Bouzidi L; Triki H; Charfi S; Kridis WB; Derbel M; Ayadi L; Sellami-Boudawara T; Cherif B
Clin Breast Cancer; 2021 Dec; 21(6):e738-e747. PubMed ID: 33727019
[TBL] [Abstract][Full Text] [Related]
2. Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?
Rathore AS; Goel MM; Makker A; Kumar S; Srivastava AN
Asian Pac J Cancer Prev; 2014; 15(8):3757-61. PubMed ID: 24870789
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
Front Immunol; 2020; 11():1242. PubMed ID: 32714321
[No Abstract] [Full Text] [Related]
4. NK Cell Infiltrates and HLA Class I Expression in Primary HER2
Muntasell A; Rojo F; Servitja S; Rubio-Perez C; Cabo M; Tamborero D; Costa-García M; Martínez-Garcia M; Menéndez S; Vazquez I; Lluch A; Gonzalez-Perez A; Rovira A; López-Botet M; Albanell J
Clin Cancer Res; 2019 Mar; 25(5):1535-1545. PubMed ID: 30523021
[TBL] [Abstract][Full Text] [Related]
5. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
Rezaeifard S; Talei A; Shariat M; Erfani N
Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer.
Cherif B; Triki H; Charfi S; Bouzidi L; Kridis WB; Khanfir A; Chaabane K; Sellami-Boudawara T; Rebai A
Sci Rep; 2021 Apr; 11(1):7550. PubMed ID: 33824367
[TBL] [Abstract][Full Text] [Related]
7. CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration.
Triki H; Charfi S; Bouzidi L; Ben Kridis W; Daoud J; Chaabane K; Sellami-Boudawara T; Rebai A; Cherif B
Life Sci; 2019 Aug; 231():116543. PubMed ID: 31176775
[TBL] [Abstract][Full Text] [Related]
8. Variable natural killer function of tumour-infiltrating lymphocytes from breast carcinomas.
Gudmundsdóttir I; Ogmundsdóttir HM
APMIS; 1992 Aug; 100(8):737-46. PubMed ID: 1325805
[TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
11. A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients.
Kim R; Kawai A; Wakisaka M; Funaoka Y; Yasuda N; Hidaka M; Morita Y; Ohtani S; Ito M; Arihiro K
Cancer Immunol Immunother; 2019 Apr; 68(4):577-585. PubMed ID: 30673828
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of natural killer cell infiltration in hepatocellular carcinoma].
Zhu LY; Zhou J; Liu YZ; Pan WD
Ai Zheng; 2009 Nov; 28(11):1198-202. PubMed ID: 19895742
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer.
Criscitiello C; Vingiani A; Maisonneuve P; Viale G; Viale G; Curigliano G
Breast Cancer Res Treat; 2020 Sep; 183(2):347-354. PubMed ID: 32621251
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Stangl S; Tontcheva N; Sievert W; Shevtsov M; Niu M; Schmid TE; Pigorsch S; Combs SE; Haller B; Balermpas P; Rödel F; Rödel C; Fokas E; Krause M; Linge A; Lohaus F; Baumann M; Tinhofer I; Budach V; Stuschke M; Grosu AL; Abdollahi A; Debus J; Belka C; Maihöfer C; Mönnich D; Zips D; Multhoff G
Int J Cancer; 2018 May; 142(9):1911-1925. PubMed ID: 29235112
[TBL] [Abstract][Full Text] [Related]
15. The prognostic benefit of tumour-infiltrating Natural Killer cells in endometrial cancer is dependent on concurrent overexpression of Human Leucocyte Antigen-E in the tumour microenvironment.
Versluis MAC; Marchal S; Plat A; de Bock GH; van Hall T; de Bruyn M; Hollema H; Nijman HW
Eur J Cancer; 2017 Nov; 86():285-295. PubMed ID: 29059634
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
17. CD16
Frazao A; Messaoudene M; Nunez N; Dulphy N; Roussin F; Sedlik C; Zitvogel L; Piaggio E; Toubert A; Caignard A
Cancer Immunol Res; 2019 Feb; 7(2):208-218. PubMed ID: 30514793
[TBL] [Abstract][Full Text] [Related]
18. Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.
Garcia-Chagollan M; Carranza-Torres IE; Carranza-Rosales P; Guzmán-Delgado NE; Ramírez-Montoya H; Martínez-Silva MG; Mariscal-Ramirez I; Barrón-Gallardo CA; Pereira-Suárez AL; Aguilar-Lemarroy A; Jave-Suárez LF
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764499. PubMed ID: 29558872
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients.
Xu B; Chen L; Li J; Zheng X; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(46):74904-74916. PubMed ID: 27736796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
